HLB increases stake in HLB Genex to 38.12%... potential dilution from conversion price adjustment
HLB increased its holdings in HLB Genex to 14,187,270 shares as of June 18, 2026, raising its ownership from 36.83% to 38.12%.
The increase resulted from open market purchases of 14,000 shares by special relation Jin Yang-gon and a conversion price adjustment on HLB's convertible bonds, adding 730,424 potential shares.
The conversion price was lowered from 2,375 KRW to 2,220 KRW, increasing potential share dilution for existing shareholders, though the higher controlling stake provides management stability.
A key contract includes a call option agreement with The Global Asset Management for a 150 million KRW CB.
[AI Summary]HLB strengthened its control over HLB Genex but the reduced conversion price raises potential equity dilution risk. The move is neutral for near-term stock price but improves long-term governance stability.